KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Depreciation & Amortization (CF) (2020 - 2025)

Boston Scientific's Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $365.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 4.89% year-over-year to $365.0 million; the TTM value through Dec 2025 reached $1.4 billion, up 7.8%, while the annual FY2025 figure was $1.4 billion, 7.8% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $365.0 million at Boston Scientific, up from $342.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $365.0 million in Q4 2025 and bottomed at $263.0 million in Q2 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $299.0 million (2023), against an average of $303.1 million.
  • The largest annual shift saw Depreciation & Amortization (CF) dropped 4.36% in 2021 before it grew 11.76% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $290.0 million in 2021, then grew by 1.38% to $294.0 million in 2022, then rose by 6.46% to $313.0 million in 2023, then rose by 11.18% to $348.0 million in 2024, then increased by 4.89% to $365.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Depreciation & Amortization (CF) are $365.0 million (Q4 2025), $342.0 million (Q3 2025), and $336.0 million (Q2 2025).